Home » Topics » Regulatory

Regulatory
RSS

FDA approves Jivi for hemophilia A

Aug. 31, 2018

Virus-based vaccine shows promise as candidate for Zika virus

Aug. 30, 2018

Inovelon receives marketing authorisation extension in Europe

Aug. 29, 2018

FDA approves Xerava to treat complicated intra-abdominal infections

Aug. 28, 2018

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

Aug. 27, 2018

FDA approves Inveltys for post-operative inflammation and pain

Aug. 24, 2018

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

Ono announces new Japanese approvals for Opdivo

Aug. 22, 2018

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Aug. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...